查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
全球藥物濫用治療市場研究報告 - 行業分析、規模、佔有率、成長、趨勢及2023年至2030年預測
市場調查報告書
商品編碼
1305286

全球藥物濫用治療市場研究報告 - 行業分析、規模、佔有率、成長、趨勢及2023年至2030年預測

Global Substance Abuse Treatment Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2023 to 2030
出版日期: | 出版商: Value Market Research | 英文 141 Pages | 商品交期: 最快1-2個工作天內

價格

藥物濫用治療市場的全球需求預計將從2022年的118.9億美元成長到2030年的近267.6億美元，2023-2030年的複合年成長率為10.67%。

藥物濫用治療是指一系列用於幫助個人克服藥物或酒精成癮的干涉和療法。藥物濫用治療涉及不同的方法，包括行為療法、藥物輔助治療和支持小組。行為療法包括幫助個人改變與吸毒或酗酒有關的態度和行為。這些療法可以在個人或團體環境中進行，可能包括認知行為療法、動機訪談和應急管理。藥物輔助治療包括使用美沙酮、丁丙諾啡和納曲酮等藥物來減少與成癮相關的渴求和戒斷症狀。這些藥物通常與行為療法結合使用。

市場動態：

包括鴉片類藥物成癮在內的藥物濫用疾病發病率不斷上升，推動了對藥物濫用治療服務的需求。各國政府正在實施相關政策和計劃，以應對鴉片類藥物的流行並增加藥物濫用治療服務的可及性。美國藥物濫用和精神健康服務管理局（SAMHSA）為藥物濫用治療項目提供資金支持。藥物濫用治療的新藥物和新療法的開發取得了進展。丁丙諾啡（buprenorphine）和納曲酮（naltrexone）等藥物已被證明可有效治療鴉片類藥物成癮，而認知行為療法（cognitive-behavioral therapy）和動機訪談（motivational interviewing）等行為療法也很有效。人們越來越意識到並接受藥物濫用障礙是一種需要治療的疾病。這減少了與尋求治療相關的恥辱感，增加了對藥物濫用治療服務的需求。人們對門診藥物濫用治療服務的需求日益成長，這種服務允許患者在接受治療的同時繼續工作或上學，從而促進了更多門診治療項目的發展，增加了獲得治療的機會。

研究報告包括波特五力模型、市場吸引力分析和價值鏈分析。這些工具有助於清晰地了解行業結構，評估全球範圍內的競爭吸引力。此外，這些工具還對全球藥物濫用治療市場的各個細分市場進行了全面評估。藥物濫用治療行業的成長和趨勢為本研究提供了全面的方法。

市場細分：

藥物濫用治療市場報告的這一部分提供了國家和地區層面細分市場的詳細數據，從而幫助戰略家確定各自產品或服務的目標人群以及即將到來的機會。

按治療類型

  • 煙草/尼古丁和吸煙
  • 酒精類
  • 大麻
  • 合成大麻素
  • 處方藥和非處方藥
  • 其他

按最終用途分類

  • 醫院
  • 診所
  • 康復中心
  • 其他

區域分析

本節涵蓋區域前景，重點介紹北美、歐洲、亞太、拉丁美洲、中東和非洲地區藥物濫用治療市場的當前和未來需求。此外，報告還重點關注了所有主要地區各個應用領域的需求、估計和預測。

該研究報告還涵蓋了市場主要參與者的綜合概況以及全球競爭格局的深入分析。藥物濫用治療市場的主要參與者包括Teva Pharmaceutical Industries Ltd.、Abbott、GSK plc.、Cipla Inc.、Lilly (Eli Lilly and Company)、Novartis AG、Sun Pharmaceutical Industries Ltd.、Dr. Reddy's Laboratories Ltd.、Viatris Inc.、AstraZeneca。本部分包括競爭格局的整體視圖，其中包括各種戰略發展，如關鍵併購、未來能力、合作夥伴關係、財務概況、合作、新產品開發、新產品上市和其他發展。

如果您有任何客製化要求，請聯繫我們。我們的研究團隊可以根據您的需求提供客製化報告。

目 錄

第一章：前言

  • 報告描述
    • 報告目標
    • 目標受眾
    • 獨特銷售主張（USP）和產品
  • 研究範圍
  • 研究方法
    • 市場調研流程
    • 市場調研方法

第二章：執行摘要

  • 市場亮點
  • 全球市場概況

第三章：藥物濫用治療-行業分析

  • 簡介- 市場動態
  • 市場驅動因素
  • 市場限制因素
  • 市場機會
  • 行業趨勢
  • 波特五力分析
  • 市場吸引力分析
    • 按治療類型分類的市場吸引力分析
    • 按最終用途的市場吸引力分析
    • 市場吸引力分析：按地區

第四章：價值鏈分析

  • 價值鏈分析
  • 原料分析
    • 原料清單
    • 原料製造商列表
    • 主要原料價格走勢
  • 潛在買家名單
  • 行銷管道
    • 直接行銷
    • 間接行銷
    • 行銷管道發展趨勢

第五章：全球藥物濫用治療市場分析：按治療類型分類

  • 治療類型概述
  • 歷史和預測數據
  • 按治療類型分析
  • 煙草/尼古丁和吸煙
  • 酒精類
  • 大麻
  • 合成大麻素
  • 處方藥和非處方藥
  • 其他

第6章：全球藥物濫用治療市場分析：按最終用途分類

  • 按最終用途概述
  • 歷史和預測數據
  • 按最終用途分析
  • 醫院
  • 診所
  • 康復中心
  • 其他

第七章：全球藥物濫用治療市場分析：按地域分類

  • 地區展望
  • 地區介紹
  • 北美銷售分析
    • 概述、歷史和預測數據銷售分析
    • 北美地區銷售分析
    • 北美各國銷售分析
    • 美國銷售分析
    • 加拿大銷售分析
    • 墨西哥銷售分析
  • 歐洲銷售分析
    • 概述、歷史和預測數據銷售分析
    • 歐洲銷售分析
    • 歐洲各國銷售分析
    • 英國銷售分析
    • 法國銷售分析
    • 德國銷售分析
    • 義大利銷售分析
    • 俄羅斯銷售分析
    • 歐洲其他地區銷售分析
  • 亞太地區銷售分析
    • 概述、歷史和預測數據銷售分析
    • 亞太地區細分市場銷售分析
    • 亞太地區各國銷售分析
    • 中國銷售分析
    • 印度銷售分析
    • 日本銷售分析
    • 韓國銷售分析
    • 澳大利亞銷售分析
    • 亞太其他地區銷售分析
  • 拉丁美洲銷售分析
    • 概述、歷史和預測數據銷售分析
    • 拉丁美洲各細分市場銷售分析
    • 拉丁美洲各國銷售分析
    • 巴西銷售分析
    • 阿根廷銷售分析
    • 秘魯銷售分析
    • 智利銷售分析
    • 拉丁美洲其他地區銷售分析
  • 中東和非洲銷售分析
    • 概述、歷史和預測數據銷售分析
    • 中東及非洲地區銷售分析
    • 中東及非洲國家銷售分析
    • 沙烏地阿拉伯銷售分析
    • 阿拉伯聯合大公國銷售分析
    • 以色列銷售分析
    • 南非銷售分析
    • 中東和非洲其他地區銷售分析

第八章: 藥物濫用治療企業的競爭格局

  • 藥物濫用治療市場競爭
  • 夥伴關係/合作/協議
  • 合併與收購
  • 新產品上市
  • 其他發展

第九章: 公司概況

  • 頂級公司市場佔有率分析
  • 市場集中度
  • Teva Pharmaceutical Industries Ltd.
    • 公司概況
    • 公司收入
    • 產品
    • 近期發展
  • Abbott
    • 公司概況
    • 公司收入
    • 產品
    • 近期發展
  • GSK plc.
    • 公司概況
    • 公司收入
    • 產品
    • 近期發展
  • Cipla Inc.
    • 公司概況
    • 公司收入
    • 產品
    • 近期發展
  • Lilly (Eli Lilly and Company)
    • 公司概況
    • 公司收入
    • 產品
    • 近期發展
  • Novartis AG
    • 公司概況
    • 公司收入
    • 產品
    • 近期發展
  • Sun Pharmaceutical Industries Ltd.
    • 公司概況
    • 公司收入
    • 產品
    • 近期發展
  • Dr. Reddy's Laboratories Ltd.
    • 公司概況
    • 公司收入
    • 產品
    • 近期發展
  • Viatris Inc.
    • 公司概況
    • 公司收入
    • 產品
    • 近期發展
  • AstraZeneca
    • 公司概況
    • 公司收入
    • 產品
    • 近期發展

注-在公司概況中，財務細節和近期發展視情況而定，如果是私營公司則可能不包括在內。

Product Code: VMR112110780

The global demand for Substance Abuse Treatment Market is presumed to reach the market size of nearly USD 26.76 BN by 2030 from USD 11.89 BN in 2022 with a CAGR of 10.67% under the study period 2023 - 2030.

Substance abuse treatment refers to a range of interventions and therapies that are used to help individuals overcome addiction to drugs or alcohol. Substance abuse treatment can involve different approaches, including behavioral therapies, medication-assisted treatment, and support groups. Behavioral therapies involve helping individuals to modify their attitudes and behaviors related to drug or alcohol use. These therapies can be delivered in individual or group settings and may include cognitive-behavioral therapy, motivational interviewing, and contingency management. Medication-assisted treatment involves the use of medications such as methadone, buprenorphine, and naltrexone to reduce cravings and withdrawal symptoms associated with addiction. These medications are often used in conjunction with behavioral therapies.

Market Dynamics:

The increasing prevalence of substance abuse disorders, including opioid addiction, is driving the demand for substance abuse treatment services. Governments are implementing policies and initiatives to address the opioid epidemic and increase access to substance abuse treatment services. The Substance Abuse and Mental Health Services Administration (SAMHSA) in the United States provides funding for substance abuse treatment programs. There have been advancements in the development of new medications and therapies for substance abuse treatment. Medications such as buprenorphine and naltrexone have been shown to be effective in treating opioid addiction, while behavioral therapies such as cognitive-behavioral therapy and motivational interviewing have also been effective. There is increasing awareness and acceptance of substance abuse disorders as a medical condition that requires treatment. This has reduced the stigma associated with seeking treatment and increased the demand for substance abuse treatment services. There is a growing demand for outpatient substance abuse treatment services, which allow individuals to receive treatment while continuing to work or attend school leading to the development of more outpatient treatment programs and increased access to care.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of substance abuse treatment. The growth and trends of substance abuse treatment industry provide a holistic approach to this study.

Market Segmentation:

This section of the substance abuse treatment market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Treatment Type

  • Tobacco/Nicotine And Vaping
  • Alcohol
  • Marijuana
  • Synthetic Cannabinoids
  • Prescription And Over-The-Counter Medications
  • Others

By End-Use

  • Hospitals
  • Clinics
  • Rehabilitation Centers
  • Others

Regional Analysis

This section covers the regional outlook, which accentuates current and future demand for the Substance Abuse Treatment market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the substance abuse treatment market include Teva Pharmaceutical Industries Ltd., Abbott, GSK plc., Cipla Inc., Lilly (Eli Lilly and Company), Novartis AG, Sun Pharmaceutical Industries Ltd., Dr. Reddy's Laboratories Ltd., Viatris Inc., AstraZeneca. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1 . PREFACE

  • 1.1. Report Description
    • 1.1.1. Objective
    • 1.1.2. Target Audience
    • 1.1.3. Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1. Market Research Process
    • 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3 . SUBSTANCE ABUSE TREATMENT - INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porter's Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Treatment Type
    • 3.7.2 Market Attractiveness Analysis By End-use
    • 3.7.3 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1. List of Raw Materials
    • 4.2.2. Raw Material Manufactures List
    • 4.2.3. Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1. Direct Marketing
    • 4.4.2. Indirect Marketing
    • 4.4.3. Marketing Channel Development Trend

5 . GLOBAL SUBSTANCE ABUSE TREATMENT MARKET ANALYSIS BY TREATMENT TYPE

  • 5.1 Overview by Treatment Type
  • 5.2 Historical and Forecast Data
  • 5.3 Analysis by Treatment Type
  • 5.4 Tobacco/Nicotine And Vaping Historic and Forecast Sales by Regions
  • 5.5 Alcohol Historic and Forecast Sales by Regions
  • 5.6 Marijuana Historic and Forecast Sales by Regions
  • 5.7 Synthetic Cannabinoids Historic and Forecast Sales by Regions
  • 5.8 Prescription And Over-the-counter Medications Historic and Forecast Sales by Regions
  • 5.9 Others Historic and Forecast Sales by Regions

6 . GLOBAL SUBSTANCE ABUSE TREATMENT MARKET ANALYSIS BY END-USE

  • 6.1 Overview by End-use
  • 6.2 Historical and Forecast Data
  • 6.3 Analysis by End-use
  • 6.4 Hospitals Historic and Forecast Sales by Regions
  • 6.5 Clinics Historic and Forecast Sales by Regions
  • 6.6 Rehabilitation Centers Historic and Forecast Sales by Regions
  • 6.7 Others Historic and Forecast Sales by Regions

7 . GLOBAL SUBSTANCE ABUSE TREATMENT MARKET ANALYSIS BY GEOGRAPHY

  • 7.1. Regional Outlook
  • 7.2. Introduction
  • 7.3. North America Sales Analysis
    • 7.3.1. Overview, Historic and Forecast Data Sales Analysis
    • 7.3.2. North America By Segment Sales Analysis
    • 7.3.3. North America By Country Sales Analysis
    • 7.3.4. United State Sales Analysis
    • 7.3.5. Canada Sales Analysis
    • 7.3.6. Mexico Sales Analysis
  • 7.4. Europe Sales Analysis
    • 7.4.1. Overview, Historic and Forecast Data Sales Analysis
    • 7.4.2. Europe by Segment Sales Analysis
    • 7.4.3. Europe by Country Sales Analysis
    • 7.4.4. United Kingdom Sales Analysis
    • 7.4.5. France Sales Analysis
    • 7.4.6. Germany Sales Analysis
    • 7.4.7. Italy Sales Analysis
    • 7.4.8. Russia Sales Analysis
    • 7.4.9. Rest Of Europe Sales Analysis
  • 7.5. Asia Pacific Sales Analysis
    • 7.5.1. Overview, Historic and Forecast Data Sales Analysis
    • 7.5.2. Asia Pacific by Segment Sales Analysis
    • 7.5.3. Asia Pacific by Country Sales Analysis
    • 7.5.4. China Sales Analysis
    • 7.5.5. India Sales Analysis
    • 7.5.6. Japan Sales Analysis
    • 7.5.7. South Korea Sales Analysis
    • 7.5.8. Australia Sales Analysis
    • 7.5.9. Rest Of Asia Pacific Sales Analysis
  • 7.6. Latin America Sales Analysis
    • 7.6.1. Overview, Historic and Forecast Data Sales Analysis
    • 7.6.2. Latin America by Segment Sales Analysis
    • 7.6.3. Latin America by Country Sales Analysis
    • 7.6.4. Brazil Sales Analysis
    • 7.6.5. Argentina Sales Analysis
    • 7.6.6. Peru Sales Analysis
    • 7.6.7. Chile Sales Analysis
    • 7.6.8. Rest of Latin America Sales Analysis
  • 7.7. Middle East & Africa Sales Analysis
    • 7.7.1. Overview, Historic and Forecast Data Sales Analysis
    • 7.7.2. Middle East & Africa by Segment Sales Analysis
    • 7.7.3. Middle East & Africa by Country Sales Analysis
    • 7.7.4. Saudi Arabia Sales Analysis
    • 7.7.5. UAE Sales Analysis
    • 7.7.6. Israel Sales Analysis
    • 7.7.7. South Africa Sales Analysis
    • 7.7.8. Rest Of Middle East And Africa Sales Analysis

8 . COMPETITIVE LANDSCAPE OF THE SUBSTANCE ABUSE TREATMENT COMPANIES

  • 8.1. Substance Abuse Treatment Market Competition
  • 8.2. Partnership/Collaboration/Agreement
  • 8.3. Merger And Acquisitions
  • 8.4. New Product Launch
  • 8.5. Other Developments

9 . COMPANY PROFILES OF SUBSTANCE ABUSE TREATMENT INDUSTRY

  • 9.1. Top Companies Market Share Analysis
  • 9.2. Market Concentration Rate
  • 9.3. Teva Pharmaceutical Industries Ltd.
    • 9.3.1. Company Overview
    • 9.3.2. Company Revenue
    • 9.3.3. Products
    • 9.3.4. Recent Developments
  • 9.4. Abbott
    • 9.4.1. Company Overview
    • 9.4.2. Company Revenue
    • 9.4.3. Products
    • 9.4.4. Recent Developments
  • 9.5. GSK plc.
    • 9.5.1. Company Overview
    • 9.5.2. Company Revenue
    • 9.5.3. Products
    • 9.5.4. Recent Developments
  • 9.6. Cipla Inc.
    • 9.6.1. Company Overview
    • 9.6.2. Company Revenue
    • 9.6.3. Products
    • 9.6.4. Recent Developments
  • 9.7. Lilly (Eli Lilly and Company)
    • 9.7.1. Company Overview
    • 9.7.2. Company Revenue
    • 9.7.3. Products
    • 9.7.4. Recent Developments
  • 9.8. Novartis AG
    • 9.8.1. Company Overview
    • 9.8.2. Company Revenue
    • 9.8.3. Products
    • 9.8.4. Recent Developments
  • 9.9. Sun Pharmaceutical Industries Ltd.
    • 9.9.1. Company Overview
    • 9.9.2. Company Revenue
    • 9.9.3. Products
    • 9.9.4. Recent Developments
  • 9.10. Dr. Reddy's Laboratories Ltd.
    • 9.10.1. Company Overview
    • 9.10.2. Company Revenue
    • 9.10.3. Products
    • 9.10.4. Recent Developments
  • 9.11. Viatris Inc.
    • 9.11.1. Company Overview
    • 9.11.2. Company Revenue
    • 9.11.3. Products
    • 9.11.4. Recent Developments
  • 9.12. AstraZeneca
    • 9.12.1. Company Overview
    • 9.12.2. Company Revenue
    • 9.12.3. Products
    • 9.12.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies

LIST OF TABLES

  • Market Snapshot
  • Drivers : Impact Analysis
  • Restraints : Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • List of Potential Buyers
  • Analysis by Treatment Type (USD MN)
  • Tobacco/Nicotine And Vaping Market Sales by Geography (USD MN)
  • Alcohol Market Sales by Geography (USD MN)
  • Marijuana Market Sales by Geography (USD MN)
  • Synthetic Cannabinoids Market Sales by Geography (USD MN)
  • Prescription And Over-the-counter Medications Market Sales by Geography (USD MN)
  • Others Market Sales by Geography (USD MN)
  • Analysis Market by End-use (USD MN)
  • Hospitals Market Sales by Geography (USD MN)
  • Clinics Market Sales by Geography (USD MN)
  • Rehabilitation Centers Market Sales by Geography (USD MN)
  • Others Market Sales by Geography (USD MN)
  • Global Substance Abuse Treatment Market Sales by Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United State Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • Europe Market Estimate by Country (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East & Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisition

LIST OF FIGURES

  • Research Scope of Substance Abuse Treatment Report
  • Market Research Process
  • Market Research Methodology
  • Global Substance Abuse Treatment Market Size, by Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis by Treatment Type
  • Market Attractiveness Analysis by End-use
  • Market Attractiveness Analysis by Region
  • Value Chain Analysis
  • Global Market Analysis by Treatment Type (USD MN)
  • Tobacco/Nicotine And Vaping Market Sales by Geography (USD MN)
  • Alcohol Market Sales by Geography (USD MN)
  • Marijuana Market Sales by Geography (USD MN)
  • Synthetic Cannabinoids Market Sales by Geography (USD MN)
  • Prescription And Over-the-counter Medications Market Sales by Geography (USD MN)
  • Others Market Sales by Geography (USD MN)
  • Global Market Analysis by End-use (USD MN)
  • Hospitals Market Sales by Geography (USD MN)
  • Clinics Market Sales by Geography (USD MN)
  • Rehabilitation Centers Market Sales by Geography (USD MN)
  • Others Market Sales by Geography (USD MN)
  • Global Market Sales (USD MN)
  • North America Market Sales (USD MN)
  • Europe Market Sales (USD MN)
  • Asia Pacific Market Sales (USD MN)
  • Latin America Market Sales (USD MN)
  • Middle East & Africa Market Sales (USD MN)
  • Recent Development in Industry
  • Top Companies Market Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.